HomeZBIO • NASDAQ
add
Zenas Biopharma Inc
Previous close
$17.29
Day range
$16.78 - $19.01
Year range
$16.50 - $20.50
Market cap
682.04M USD
Avg Volume
106.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.90M | 47.74% |
Net income | -37.98M | -30.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -39.67M | -110.15% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 183.93M | — |
Total assets | 199.95M | — |
Total liabilities | 39.12M | — |
Total equity | 160.83M | — |
Shares outstanding | 13.71M | — |
Price to book | -0.82 | — |
Return on assets | -79.72% | — |
Return on capital | -109.93% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -37.98M | -30.74% |
Cash from operations | -30.96M | -48.04% |
Cash from investing | -35.00K | — |
Cash from financing | 177.74M | 1,615,709.09% |
Net change in cash | 146.78M | 807.87% |
Free cash flow | -16.60M | — |
About
Founded
2019
Headquarters
Website
Employees
114
